Cargando…

FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells

Eukaryotic elongation factor 2 kinase (eEF2K), an emerging molecular target for cancer therapy, contributes to cancer proliferation, cell survival, tumorigenesis, and invasion, disease progression and drug resistance. Although eEF2K is highly up-regulated in various cancers, the mechanism of gene re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamurcu, Zuhal, Ashour, Ahmed, Kahraman, Nermin, Ozpolat, Bulent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941339/ https://www.ncbi.nlm.nih.gov/pubmed/26918606 http://dx.doi.org/10.18632/oncotarget.7672

Ejemplares similares

MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
por: Bayraktar, Recep, et al.
Publicado: (2016)

Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
por: Bayraktar, Recep, et al.
Publicado: (2023)

Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial–mesenchymal transition mediating pancreatic cancer cells invasion
por: Ashour, Ahmed A, et al.
Publicado: (2014)

Down-Regulation of 5-HT(1B) and 5-HT(1D) Receptors Inhibits Proliferation, Clonogenicity and Invasion of Human Pancreatic Cancer Cells
por: Gurbuz, Nilgun, et al.
Publicado: (2014)

Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors
por: Wang, Liangbo, et al.
Publicado: (2023)

Aurora kinase A stabilizes FOXM1 to enhance paclitaxel resistance in triple‐negative breast cancer
por: Yang, Na, et al.
Publicado: (2019)

ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer
por: Gorur, Aysegul, et al.
Publicado: (2021)

Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase
por: Pyr Dit Ruys, Sébastien, et al.
Publicado: (2012)

Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase
por: Ruys, S. Pyr Dit, et al.
Publicado: (2012)

Elevated eukaryotic elongation factor 2 expression is involved in proliferation and invasion of lung squamous cell carcinoma
por: Song, Yang, et al.
Publicado: (2016)

Epithelial-Mesenchymal Transition Is a Critical Step in Tumorgenesis of Pancreatic Neuroendocrine Tumors
por: Fendrich, Volker, et al.
Publicado: (2012)

Identification of FOXM1 as a specific marker for triple-negative breast cancer
por: Tan, Yanli, et al.
Publicado: (2018)

Insights Into the Pathologic Roles and Regulation of Eukaryotic Elongation Factor-2 Kinase
por: Ballard, Darby J., et al.
Publicado: (2021)

Control of eukaryotic transcription elongation
por: Winston, Fred
Publicado: (2001)

Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer
por: Wang, Xuemin, et al.
Publicado: (2017)

Structural basis for the calmodulin-mediated activation of eukaryotic elongation factor 2 kinase
por: Piserchio, Andrea, et al.
Publicado: (2022)

ADP enhances the allosteric activation of eukaryotic elongation factor 2 kinase by calmodulin
por: Piserchio, Andrea, et al.
Publicado: (2023)

FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
por: Zhu, Xia, et al.
Publicado: (2020)

Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model
por: Zahavi, Tamar, et al.
Publicado: (2015)

Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells
por: Sanges, C, et al.
Publicado: (2012)

Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells
por: Sanges, C, et al.
Publicado: (2012)

The Anticancer Effects of FDI-6, a FOXM1 Inhibitor, on Triple Negative Breast Cancer
por: Ulhaka, Karan, et al.
Publicado: (2021)

Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains
por: Pigott, Craig R., et al.
Publicado: (2012)

Eukaryotic elongation factor 2 kinase regulates the synthesis of microtubule‐related proteins in neurons
por: Kenney, Justin W., et al.
Publicado: (2015)

Impairing Eukaryotic Elongation Factor 2 Kinase Activity Decreases Atherosclerotic Plaque Formation
por: Zhang, Peng, et al.
Publicado: (2014)

A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors
por: Xiao, Ting, et al.
Publicado: (2016)

Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer
por: Ng, Tung H., et al.
Publicado: (2019)

Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer
por: Tekedereli, Ibrahim, et al.
Publicado: (2012)

Osteosarcoma Cell-Derived Exosomal miR-1307 Promotes Tumorgenesis via Targeting AGAP1
por: Han, Fei, et al.
Publicado: (2021)

Identification of a novel de novo mutation of SETBP1 and new findings of SETBP1 in tumorgenesis
por: Wang, Hongdan, et al.
Publicado: (2023)

TACE responser NDRG1 acts as a guardian against ferroptosis to drive tumorgenesis and metastasis in HCC
por: Tang, Bufu, et al.
Publicado: (2023)

CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
por: Ring, Alexander, et al.
Publicado: (2018)

Inhibition of Eukaryotic Translation Elongation by Cycloheximide and Lactimidomycin
por: Schneider-Poetsch, Tilman, et al.
Publicado: (2010)

Eukaryotic Elongation Factor 2 Kinase Activity Is Required for the Phenotypes of the Rpl24(Bst) Mouse
por: Knight, John R.P., et al.
Publicado: (2022)

RNF112-mediated FOXM1 ubiquitination suppresses the proliferation and invasion of gastric cancer
por: Zhang, Shengwei, et al.
Publicado: (2023)

Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling
por: Zhao, Xiaofeng, et al.
Publicado: (2017)

Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer
por: Dey, Parama, et al.
Publicado: (2020)

Control of CD4(+) T cells to restrain inflammatory diseases via eukaryotic elongation factor 2 kinase
por: Peng, Hao-Yun, et al.
Publicado: (2023)

An evolutionary ratchet leading to loss of elongation factors in eukaryotes
por: Atkinson, Gemma C, et al.
Publicado: (2014)

Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo
por: Chen, Zhenzhen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qqv2p6bf13b3vktfedu4r557fh